Boyue Bio
Hangzhou
About Boyue Bio
Boyue Bio focuses on the development of biomedical raw materials and integrated solutions. The company's four product lines include Bioactive Materials, Nanometer Microspheres, Chromatographic Products, and Integrated Solutions. Boyue Bio seeks to be a major provider of total solutions and core raw materials for the biomedical industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $22.3M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2022)
- Website: bioeast.com
- Phone: 0571-86963020
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/boyue-bio-168855 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.